ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
08/14/2025
Back to search
Official data from USPTO
PHARMALINK, INC.
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PHARMALINK, INC.
ST13
US500000076509402Class
37
Filing
76509402
Registration
2822811
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
08/15/2025
Trademark type
Word
Nice classes
37
Filing date
04/25/2003
Registration date
03/16/2004
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/27/2023
Last transaction
08/15/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
01/11/2000
First use in commerce
01/11/2000
Drawing code
1
Owner type
16
Owner location
LARGO, FL
Examiner
EDWARDS, ALICIA
Law office
M60
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
PHARMALINK, LLC
Pharmalink, Inc.
Representatives
Nathan P. Suedmeyer Larson & Larson, PA
Technical classification
Nice Classes
Class 37
Vienna Codes
No Vienna codes available.
Goods and services
Class 37
PHARMACEUTICAL RETURNS AND DISPOSAL SERVICES
Publications
History of USPTO decisions and trademark events.
29 publications found
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
08/06/2025
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
09/27/2023
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
09/27/2023
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/27/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/27/2023
E89R
TEAS SECTION 8 & 9 RECEIVED
03/23/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
03/16/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/06/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/06/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/06/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/06/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/06/2020
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
03/19/2013
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
03/19/2013
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
03/19/2013
E89R
TEAS SECTION 8 & 9 RECEIVED
03/18/2013
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/13/2010
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
09/13/2010
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
04/27/2009
PLGL
ASSIGNED TO PARALEGAL
04/06/2009
E815
TEAS SECTION 8 & 15 RECEIVED
04/02/2009
R.PR
REGISTERED-PRINCIPAL REGISTER
03/16/2004
PUBO
PUBLISHED FOR OPPOSITION
12/23/2003
NPUB
NOTICE OF PUBLICATION
12/03/2003
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/17/2003
CNEA
EXAMINERS AMENDMENT MAILED
10/10/2003
CNRT
NON-FINAL ACTION MAILED
09/30/2003
DOCK
ASSIGNED TO EXAMINER
09/27/2003
Continuous trademark protection
Get notified about every new filing that threatens PHARMALINK, INC. or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.